Chemotherapy-Induced Distal Enhancers Drive Transcriptional Programs to Maintain the Chemoresistant State in Ovarian Cancer
Stephen Shang(University of Virginia), Mazhar Adli(University of Virginia), Turan Tufan(University of Virginia), Mouadh Benamar(University of Virginia), Charles N. Landen(University of Virginia), Philip J. Ebert(Eli Lilly (United States)), Peter C. Scacheri(University School), Natasha Lopes Fischer(University of Pennsylvania), Tarek Abbas(University of Virginia), Jiekun Yang(Rutgers, The State University of New Jersey), Analisa DiFeo(University of Michigan), Robert M. Campbell(Children's Health Queensland Hospital and Health Service), Alexander James Duval(University of Virginia), Amir A. Jazaeri(The University of Texas MD Anderson Cancer Center), In-Young Lee(University of Virginia), Fadila Guessous(University of Virginia)
Cited by 64
Related Papers
p21 in cancer: intricate networks and multiple activities
|Nature reviews. Cancer|2009|2.8k
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
|Proceedings of the National Academy of Sciences|2003|2k
Histone Modifications and Cancer
|Cold Spring Harbor Perspectives in Biology|2016|1.1k
Genomewide Analysis of PRC1 and PRC2 Occupancy Identifies Two Classes of Bivalent Domains
|PLoS Genetics|2008|1k
Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance
|Nature Medicine|2023|508